Alvaxanthone, a Thymidylate Synthase Inhibitor with Nematocidal and Tumoricidal Activities.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
23 Jun 2020
Historique:
received: 03 05 2020
revised: 15 06 2020
accepted: 19 06 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 20 2 2021
Statut: epublish

Résumé

With the aim to identify novel inhibitors of parasitic nematode thymidylate synthase (TS), we screened in silico an in-house library of natural compounds, taking advantage of a model of nematode TS three-dimensional (3D) structure and choosing candidate compounds potentially capable of enzyme binding/inhibition. Selected compounds were tested as (i) inhibitors of the reaction catalyzed by TSs of different species, (ii) agents toxic to a nematode parasite model (

Identifiants

pubmed: 32586022
pii: molecules25122894
doi: 10.3390/molecules25122894
pmc: PMC7356228
pii:
doi:

Substances chimiques

Antinematodal Agents 0
Antineoplastic Agents 0
Enzyme Inhibitors 0
Small Molecule Libraries 0
Xanthones 0
alvaxanthone 0
Adenosine Triphosphate 8L70Q75FXE
Thymidylate Synthase EC 2.1.1.45
Caspase 3 EC 3.4.22.-
Caspase 7 EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Narodowe Centrum Nauki
ID : 2016/21/BNZ1/00288

Références

Z Naturforsch C J Biosci. 2016;71(5-6):121-31
pubmed: 27140303
J Med Chem. 2015 Sep 10;58(17):7076-87
pubmed: 26295373
Drug Discov Today. 2006 Jul;11(13-14):607-15
pubmed: 16793529
J Mol Graph Model. 2017 Oct;77:33-50
pubmed: 28826032
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Biochim Biophys Acta. 2015 Dec;1854(12):1922-1934
pubmed: 26315778
Chem Biol Interact. 2016 Dec 25;260:248-255
pubmed: 27720947
Cell Death Dis. 2014 Sep 04;5:e1406
pubmed: 25188516
Cancer Cell. 2004 Apr;5(4):341-51
pubmed: 15093541
Parasitology. 2000 Jun;120 ( Pt 6):593-600
pubmed: 10874722
J Clin Invest. 2008 Apr;118(4):1311-21
pubmed: 18382743
Bioorg Med Chem. 2010 May 15;18(10):3361-70
pubmed: 20430630
Biochem Pharmacol. 1987 Jan 15;36(2):203-10
pubmed: 3814166
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Planta Med. 2005 Mar;71(3):273-4
pubmed: 15770550
Toxins (Basel). 2019 Sep 01;11(9):
pubmed: 31480508
J Biol Chem. 2017 Aug 11;292(32):13449-13458
pubmed: 28634233
Curr Med Chem. 2005;12(2):191-202
pubmed: 15638735
Drug Resist Updat. 2015 Nov;23:20-54
pubmed: 26690339
Eur J Pharmacol. 2019 Nov 15;863:172678
pubmed: 31542481
J Med Chem. 2002 Jun 6;45(12):2615-23
pubmed: 12036371
Chem Biodivers. 2004 Sep;1(9):1385-90
pubmed: 17191916
Acta Biochim Pol. 1993;40(3):363-8
pubmed: 8249493
MLO Med Lab Obs. 2001 Jan;33(1):24-31; quiz 32-3
pubmed: 11211415
J Med Chem. 2017 Mar 9;60(5):1620-1637
pubmed: 28074653
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
J Invest Dermatol. 2016 Jan;136(1):e1-e7
pubmed: 26763463
Curr Med Chem. 2005;12(19):2241-58
pubmed: 16178783
J Chem Inf Model. 2011 Mar 28;51(3):578-96
pubmed: 21323318
Pharmacol Res. 2018 Mar;129:500-514
pubmed: 29197639
Cancer J Sci Am. 1998 Sep-Oct;4(5):287-95
pubmed: 9815290
Bioinformatics. 2017 Nov 15;33(22):3658-3660
pubmed: 28961788
Sci Rep. 2017 May 19;7(1):2213
pubmed: 28526832
J Cell Biol. 2001 Apr 16;153(2):319-28
pubmed: 11309413
PLoS One. 2019 Mar 25;14(3):e0205623
pubmed: 30908483
Antimicrob Agents Chemother. 1996 Feb;40(2):279-91
pubmed: 8834867
Mini Rev Med Chem. 2008 Apr;8(4):388-98
pubmed: 18473929
Cell Death Dis. 2016 Sep 22;7(9):e2376
pubmed: 27899820
Phytomedicine. 2005 Jun;12(6-7):510-3
pubmed: 16008130
Sci Rep. 2019 Apr 11;9(1):5935
pubmed: 30976058
Int J Parasitol. 1998 Mar;28(3):395-411
pubmed: 9559358
Expert Rev Anti Infect Ther. 2013 Dec;11(12):1363-76
pubmed: 24180514
ChemMedChem. 2006 Nov;1(11):1229-36
pubmed: 16991174
ChemMedChem. 2016 Jun 6;11(11):1117-21
pubmed: 27218427
Anticancer Drugs. 1997 Jan;8(1):3-16
pubmed: 9147608
EMBO J. 2015 Jan 13;34(2):200-17
pubmed: 25476449
Int J Parasitol. 2000 Nov;30(12-13):1339-49
pubmed: 11113259
J Chem Inf Model. 2010 Apr 26;50(4):572-84
pubmed: 20235588
J Vet Pharmacol Ther. 1990 Sep;13(3):223-47
pubmed: 2231864
Apoptosis. 2011 Apr;16(4):404-24
pubmed: 21311976
Parasitology. 2005 Aug;131(Pt 2):247-54
pubmed: 16145941
J Med Chem. 2001 Jun 7;44(12):1841-6
pubmed: 11384230
Nat Commun. 2015 Jun 25;6:7485
pubmed: 26108372
J Med Chem. 2000 Oct 19;43(21):3867-77
pubmed: 11052792
J Nat Prod. 2001 Jan;64(1):65-70
pubmed: 11170668

Auteurs

Piotr Maj (P)

Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093 Warsaw, Poland.
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.

Mattia Mori (M)

Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018-2022, via Aldo Moro 2, 53100 Siena, Italy.

Justyna Sobich (J)

Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093 Warsaw, Poland.

Joanna Markowicz (J)

Faculty of Chemistry, Rzeszów University of Technology, 6 Powstańców Warszawy Ave, 35-959 Rzeszów, Poland.

Łukasz Uram (Ł)

Faculty of Chemistry, Rzeszów University of Technology, 6 Powstańców Warszawy Ave, 35-959 Rzeszów, Poland.

Zbigniew Zieliński (Z)

Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093 Warsaw, Poland.

Deborah Quaglio (D)

Department of Chemistry and Technology of Drugs, Department of Excellence 2018-2022, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Andrea Calcaterra (A)

Department of Chemistry and Technology of Drugs, Department of Excellence 2018-2022, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Ylenia Cau (Y)

Department of Biotechnology, Chemistry and Pharmacy, Department of Excellence 2018-2022, via Aldo Moro 2, 53100 Siena, Italy.

Bruno Botta (B)

Department of Chemistry and Technology of Drugs, Department of Excellence 2018-2022, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Wojciech Rode (W)

Nencki Institute of Experimental Biology, 3 Pasteur Street, 02-093 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH